BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33320344)

  • 1. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival.
    Hammad AY; Berger NG; Eastwood D; Tsai S; Turaga KK; Christian KK; Johnston FM; Pawlik TM; Gamblin TC
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):912-920. PubMed ID: 27654107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    J Gastrointest Surg; 2021 Jul; 25(7):1805-1814. PubMed ID: 33230687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.
    Dover LL; Oster RA; McDonald AM; DuBay DA; Wang TN; Jacob R
    HPB (Oxford); 2016 Oct; 18(10):843-850. PubMed ID: 27542590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study.
    Kamarajah SK; Al-Rawashdeh W; Parente A; Atherton P; Salti GI; Dahdaleh FS; Manas D; Hilal MA; White SA
    Eur J Surg Oncol; 2022 Jun; 48(6):1300-1308. PubMed ID: 34916085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
    Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
    Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
    Shi XQ; Zhang JY; Tian H; Tang LN; Li AL
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):549-559. PubMed ID: 32633109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma.
    Chua TC; Mittal A; Arena J; Sheen A; Gill AJ; Samra JS
    Am J Surg; 2017 Jun; 213(6):1072-1076. PubMed ID: 27751529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resectable intrahepatic and hilar cholangiocarcinoma: Is margin status associated with survival?
    Littau MJ; Kim P; Kulshrestha S; Bunn C; Tonelli C; Abdelsattar ZM; Luchette FA; Baker MS
    Surgery; 2022 Mar; 171(3):703-710. PubMed ID: 34872744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.
    Fuller CD; Wang SJ; Choi M; Czito BG; Cornell J; Welzel TM; McGlynn KA; Luh JY; Thomas CR
    Cancer; 2009 Nov; 115(22):5175-83. PubMed ID: 19637356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
    Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
    Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.